Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 40
Encontrada(s) 1 página(s)

Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

From premorbid adjustment dimensions to clinical outcomes: exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypes

  • Perez-Ramos, Anaid
  • Gonzalez-Segura, Àlex
  • Julià, Laura
  • García-Rizo, Clemente
  • Sánchez Torres, Ana María
  • Cavone, Vito
  • Zorrilla, Iñaki
  • Mané, Anna
  • Rodríguez-Jiménez, Roberto
  • Roldán, Alexandra
  • Pomarol-Clotet, Edith
  • Ibáñez, Ángela
  • Usall, Judith
  • Lobo, Antonio
  • Bioque, Miquel
  • Bernardo, Miguel
  • Cuesta, Manuel J.
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Esther
  • Amoretti, Silvia
  • Mezquida, Gisela
  • 2EPs Working Group
Introduction Schizophrenia is a complex and multifaceted mental disorder characterized by cognitive, emotional, and behavioral dysfunctions that significantly impact the patients' daily lives. Premorbid adjustment (PA) is a multidimensional framework, the severity of which has been associated with more severe phenotypic traits and unfavorable outcomes, offering insights into the development of this disorder. This study aims to characterize a group of first-episode schizophrenia (FES) patients based on academic (PAA) and social (PSA) PA, explore the overlap across these dimensions, and examine their associations with early clinical, environmental, and epigenetic factors, through methylation profile scores (MPS). Material and methods A total of 218 FES subjects were included. K-means clustering identified "poor" and "good" groups for PAA and PSA. Clusters overlaps were explored using multiple correspondence analysis and were characterized by sociodemographic, clinical, functional, and cognitive features. Associations with clinical, environmental factors and MPS were examined using multivariable models adjusted for key covariates. Results Poor-PAA individuals showed worse cognitive performance (working memory, attention, and executive function), lower educational level, and higher cannabis use. Poor-PSA individuals had more severe negative symptoms. MPS for early-life adversity and cannabis use were associated with PSA clusters, while MPS for birth weight and tobacco use were linked to PAA clusters. Conclusions PAA and PSA dimensions show distinct clinical, cognitive, functional, and epigenetic profiles. These findings support the use of premorbid functioning subtypes for identifying early markers and tailoring interventions., This study is part of a coordinated multicenter project funded by the Ministerio de Economía y Competitividad (PI08/0208, PI11/00325, PI14/00612) (M.B.); the Instituto de Salud Carlos III and the European Regional Development Fund (ERDF), A way to build Europe; the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM); the CERCA Programme/Generalitat de Catalunya; and the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2021 SGR 01120). Furthermore, this study is part of the projects PI24/00196 (C.G.-R. and G.M.) funded by Instituto de Salud Carlos II (ISCIII) and co-financed by the European Union, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, ERCA Program/Generalitat de Catalunya and Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2017SGR1355). G.M. is a Serra Hunter Fellow, within the Tenure-elegible Lecturer Serra Hunter program (UB-LE-212-024, Generalitat de Catalunya). Supported by the Madrid Regional Government (R&D activities in Biomedicine S2022/BMD-7216 (AGES 3-CM), and CIBERSAM-ISCIII.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory

  • Ballesteros, Alejandro
  • Sánchez Torres, Ana María
  • López-Ilundain, José M.
  • Mezquida, Gisela
  • Lobo, Antonio
  • González Pinto, Ana
  • Pina-Camacho, Laura
  • Corripio, Iluminada
  • Vieta, Eduard
  • Serna, Elena de la
  • Mané, Anna
  • Bioque, Miquel
  • Moreno-Izco, Lucía
  • Espliego, Ana
  • Lorente Omeñaca, Ruth
  • Amoretti, Silvia
  • Bernardo, Miguel
  • Cuesta, Manuel J.
  • PEPs Group
Background. Previous literature supports antipsychotics¿ (AP) efficacy in acute first-episode psychosis (FEP) in terms of symptomatology and functioning but also a cognitive detrimental effect. However, regarding functional recovery in stabilised patients, these effects are not clear. Therefore, the main aim of this study is to investigate dopaminergic/anticholinergic burden of (AP) on psychosocial functioning in FEP. We also examined whether cognitive impairment may mediate these effects on functioning. Methods. A total of 157 FEP participants were assessed at study entry, and at 2 months and 2 years after remission of the acute episode. The primary outcomes were social functioning as measured by the functioning assessment short test (FAST). Cognitive domains were assessed as potential mediators. Dopaminergic and anticholinergic AP burden on 2-year psychosocial functioning [measured with chlorpromazine (CPZ) and drug burden index] were independent variables. Secondary outcomes were clinical and socio-demographic variables. Results. Mediation analysis found a statistical but not meaningful contribution of dopaminergic receptor blockade burden to worse functioning mediated by cognition (for every 600 CPZ equivalent points, 2-year FAST score increased 1.38 points). Regarding verbal memory and attention, there was an indirect effect of CPZ burden on FAST (b = 0.0045, 95% CI 0.0011¿0.0091) and (b = 0.0026, 95% CI 0.0001¿0.0006) respectively. However, only verbal memory post hoc analyses showed a significant indirect effect (b = 0.009, 95% CI 0.033¿0.0151) adding premorbid IQ as covariate. We did not find significant results for anticholinergic burden. Conclusion. CPZ dose effect over functioning is mediated by verbal memory but this association appears barely relevant., This study is part of a coordinated, multicentre project funded by the Ministerio de Economía y Competitividad (PI08/0208; 08/1026; 11/02831; PI08/1161; PI14/1621), Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional, and European Union. Una manera de hacer Europa (FEDER Funds). The Health Department of the Government of Navarra (87/2014). CERCA Programme/Generalitat de Catalunya; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2014|SGR1636, 2014SGR441) and Fundación Alicia Koplowitz.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

From genetics to psychosocial functioning: unraveling the mediating roles of cognitive reserve, cognition, and negative symptoms in first-episode psychosis

  • Forte, María Florencia
  • Clougher, Derek
  • Segura, Àlex G.
  • Sánchez Torres, Ana María
  • Vieta, Eduard
  • Garriga, Marina
  • Lobo, Antonio
  • González Pinto, Ana
  • Díaz-Caneja, Covadonga M.
  • Roldán, Alexandra
  • Martínez-Aran, Anabel
  • Serna, Elena de la
  • Mané, Anna
  • Mas, Sergi
  • Torrent, Carla
  • Allot, Kelly
  • Bernardo, Miguel
  • Amoretti, Silvia
  • PEPs Group
  • Iris Rodríguez, Corina
Background: Studies have shown associations between polygenic risk scores for educational attainment (PRSEA), cognitive reserve (CR), cognition, negative symptoms (NS), and psychosocial functioning in first-episode psychosis (FEP). However, theirspecific interactions remain unclear. This study aimed to investigate the mediating roles of CR, cognition, and NS in the relationship between PRSEA and psychosocial functioning one year after a FEP. Additionally, we sought to explore the impact of two NSsubtypes on this relationship: diminished Expression (EXP-NS) and Motivation and Pleasure (MAP-NS). Methods: A total of 138 FEP participants, predominantly male (70%), with a mean age of 24.77 years (SD = 5.29), underwent genetic, clinical, and cognitive assessments two months after study enrollment. Functioning evaluation followed at one-year follow-up. To investigate the mediating role of CR, cognition, and NS in the relationship between PRSEA and functioning, a serial mediation model was employed. Two further mediation models were tested to explore the differential impact of EXP-NS and MAP-NS. Mediation analysis was performed using the PROCESS macro version 4.1 within SPSS version 26. Results: The serial mediation model revealed a causal chain for PRSEA > CR > cognition > NS > Functioning (β = −3.08, 95%CI[−5.73, −0.43], p = 0.023). When differentiating by type of NS, only EXP-NS were significantly associated in the casual chain (β = −0.17, 95% CI [−0.39, −0.01], p < 0.05). Conclusions: CR, cognition and NS -specifically EXP-NS- mediate the association between PRSEA and psychosocial functioning at one-year follow-up in FEP patients. These results highlight the potential for personalized interventions based on genetic predisposition., This study is part of a coordinated-multicentre Project, funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional. Unión Europea. Una manera de hacer Europa.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females

  • Serra-Navarro, María
  • Amoretti, Silvia
  • Verdolini, Norma
  • Forte, María Florencia
  • Sánchez Torres, Ana María
  • Vieta, Eduard
  • Clougher, Derek
  • Lobo, Antonio
  • González Pinto, Ana
  • Panadero-Gómez, Rocío
  • Roldán, Alexandra
  • Carvalho, André F.
  • Serna, Elena de la
  • Toll, Alba
  • Ramos-Quiroga, Josep Antoni
  • Torrent, Carla
  • Cuesta, Manuel J.
  • Bernardo, Miguel
  • PEPs Group
Background: Deficits in psychosocial functioning are present in the early stages of psychosis. Several factors, such as premorbid adjustment, neurocognitive performance, and cognitive reserve (CR), potentially influence functionality. Sex differences are observed in individuals with psychosis in multiple domains. Nonetheless, few studies have explored the predictive. factors of poor functioning according to sex in first-episode psychosis (FEP). This study aimed to explore sex differences, examine changes, and identify predictors of functioning according to sex after onset. Materials and methods: The initial sample comprised 588 individuals. However, only adults with non-affective FEP (n = 247, 161 males and 86 females) and healthy controls (n = 224, 142 males and 82 females) were included. A comprehensive assessment including functional, neuropsychological, and clinical scales was performed at baseline and at 2-year follow-up. A linear regression model was used to determine the predictors of functioning at 2-year follow-up. Results: FEP improved their functionality at follow-up (67.4% of both males and females). In males, longer duration of untreated psychosis (β = 0.328, p = 0.003) and worse premorbid adjustment (β = 0.256, p = 0.023) were associated with impaired functioning at 2-year follow-up, while in females processing speed (β = 0.403, p = 0.003), executive function (β = 0.299, p = 0.020) and CR (β = −0.307, p = 0.012) were significantly associated with functioning. Conclusion: Our data indicate that predictors of functioning at 2-year followup in the FEP group differ according to sex. Therefore, treatment and preventative efforts may be adjusted taking sex into account. Males may benefit from functional remediation at early stages. Conversely, in females, early interventions centered on CR enhancement and cognitive rehabilitation may be recommended., This study was funded with the projects PI17/01066 and PI20/00344 by the Instituto de Salud Carlos III and co-funded by the Unión Europea (FEDER) "Una manera de hacer Europa".
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis: a two-year follow-up study

  • Clougher, Derek
  • Forte, María Florencia
  • Mezquida, Gisela
  • Sánchez Torres, Ana María
  • Serra-Navarro, María
  • Penadés, Rafael
  • Lobo, Antonio
  • González Pinto, Ana
  • Panadero-Gómez, Rocío
  • Roldán, Alexandra
  • Vieta, Eduard
  • Serna, Elena de la
  • Trabsa, Amira
  • Martínez-Aran, Anabel
  • Torrent, Carla
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ramos-Quiroga, Josep Antoni
  • Cuesta, Manuel J.
  • Bernardo, Miguel
  • Amoretti, Silvia
  • PEPs Group
Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions., This study is part of a coordinated-multicentre Project, funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III Fondo Europeo de Desarrollo Regional. Unión Europea. Una manera de hacer Europa, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, by the CERCA Programme / Generalitat de Catalunya AND Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2021 SGR 01120). Departament de Salut de la Generalitat de Catalunya, en la convocatòria corresponent a l'any 2017 de concessió de subvencions del Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2016-2020, modalitat Projectes de recerca orientats a l'atenció primària, amb el codi d'expedient SLT006/17/00345.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

The role of premorbid IQ and age of onset as useful predictors of clinical, functional outcomes, and recovery of individuals with a first episode of psychosis

  • Molina-García, Mariola
  • Fraguas, David
  • Rey-Mejías, Ángel del
  • Mezquida, Gisela
  • Sánchez Torres, Ana María
  • Amoretti, Silvia
  • Lobo, Antonio
  • González Pinto, Ana
  • Andreu-Bernabeu, Álvaro
  • Corripio, Iluminada
  • Vieta, Eduard
  • Baeza, Inmaculada
  • Mané, Anna
  • Cuesta, Manuel J.
  • Serna, Elena de la
  • Payá, Beatriz
  • Zorrilla, Iñaki
  • Arango, Celso
  • Bernardo, Miguel
  • Rapado-Castro, Marta
  • Parellada, Mara
  • PEPs Group
Background: premorbid IQ (pIQ) and age of onset are predictors of clinical severity and long-term functioning after a first episode of psychosis. However, the additive influence of these variables on clinical, functional, and recovery rates outcomes is largely unknown. Methods: we characterized 255 individuals who have experienced a first episode of psychosis in four a priori defined subgroups based on pIQ (low pIQ < 85; average pIQ ≥ 85) and age of onset (early onset < 18 years; adult onset ≥ 18 years). We conducted clinical and functional assessments at baseline and at two-year follow-up. We calculated symptom remission and recovery rates using the Positive and Negative Symptoms of Schizophrenia Schedule (PANSS) and the Global Assessment Functioning (GAF or Children-GAF). We examined clinical and functional changes with pair-wise comparisons and two-way mixed ANOVA. We built hierarchical lineal and logistic regression models to estimate the predictive value of the independent variables over functioning or recovery rates. Results: early-onset patients had more severe positive symptoms and poorer functioning than adult-onset patients. At two-year follow-up, only early-onset with low pIQ and adult-onset with average pIQ subgroups differed consistently, with the former having more negative symptoms (d = 0.59), poorer functioning (d = 0.82), lower remission (61% vs. 81.1%), and clinical recovery (34.1% vs. 62.2%). Conclusions: early-onset individuals with low pIQ may present persistent negative symptoms, lower functioning, and less recovery likelihood at two-year follow-up. Intensive cognitive and functional programs for these individuals merit testing to improve long-term recovery rates in this subgroup., This work was supported by the Spanish Ministry of Science and Innovation. Instituto de Salud Carlos III, PI02/1248, PI03032, PI05/0678, PI08/0208 PI09/01442, PI11/00325, PI12/1303, PI14/00612, PI15/00723, PI17/009977, PI18/00753 cofinanced by ERDF Funds from the European Commission, 'A way of making Europe', CIBERSAM. Madrid Regional Government (B2017/BMD-3740 AGES-CM-2). The CERCA Program/Generalitat de Catalunya And Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2017SGR1355). Departament de Salut de la Generalitat de Catalunya, en la convocatoria corresponent a l'any 2017 de concessió de subvencions del Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2016-2020, modalitat Projectes de recerca orientats a l'atenció primària, amb el codi d'expedient SLT006/17/00345. European Union Structural Funds. European Union Seventh Framework Program under grant agreements FP7-HEALTH-2009-2.2.1-2-241909 (Project EU-GEI), FP7-HEALTH-2009-2.2.1-3-242114 (Project OPTi-MISE), FP7-HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN) and FP7-HEALTH-2013-2.2.1-2-602478 (Project METSY); and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement No 115916, Project PRISM, and grant agreement No 777394, Project AIMS-2-TRIALS), Fundación Familia Alonso, Fundación Alicia Koplowitz and Fundación Mutua Madrileña.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Obstetric complications, cortical gyrification, and cognition in first-episode psychosis

  • Costas-Carrera, Ana
  • Verdolini, Norma
  • Mezquida, Gisela
  • Forte, María Florencia
  • Janssen, Joost
  • García-Rizo, Clemente
  • Martínez-Aran, Anabel
  • Andres-Camazon, Pablo
  • Sánchez Torres, Ana María
  • Bergé, Daniel
  • Serna, Elena de la
  • Penadés, Rafael
  • Valli, Isabel
  • Amoretti, Silvia
  • PEPs Group
Background. Obstetric complications (OCs) are associated with cognitive and brain abnormalities observed in patients with schizophrenia. Gyrification, a measure of cortical integrity sensitive to events occurring during the prenatal and perinatal periods, is also altered in firstepisode psychosis (FEP). We examined the relationship between OCs and gyrification in FEP, as well as whether gyrification mediates the relationship between OCs and cognition. Methods. We examined differences in the Local Gyrification Index (LGI) for the frontal, parietal, temporal, occipital, and cingulate cortices between 139 FEP patients and 125 healthy controls (HCs). Regression analyses explored whether OCs and diagnosis interact to explain LGI variation. Parametric mediation analyses were conducted to assess the effect of LGI on the relationship between OCs and cognition for FEP and HC. Results. Significant LGI differences were observed between FEP patients and HC in the left parietal and bilateral cingulate and occipital cortices. There was a significant interaction between OCs and diagnosis on the left cingulate cortex (LCC) that was specific to males (p = 0.04) and was driven by gestational rather than intrauterine OCs. In HCs, OCs had a direct effect on working memory (WM) (p = 0.048) in the mediation analysis, whereas in FEP, we observed no significant effect of OCs on either verbal or WM. Conclusions. OCs interact with diagnosis to predict LCC gyrification, such that males with FEP exposed to OCs exhibit the lowest LGI. OCs influence WM, and LCC gyrification may mediate this relation only in HC, suggesting a differential neurodevelopmental process in psychosis., This study is part of a coordinated multicenter Project, PEPs study, funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional. Unión Europea. Una manera de hacer Europa, Centro de Investigacion Biomédica en Red de salud Mental, CIBERSAM, Instituto de Salud Carlos III, by the CERCA Program/Generalitat de Catalunya and Secretaria d'Universitats i Recerca of the Departament d¿Economia I Coneixement (2017SGR1355). Departament de Salut de la Generalitat de Catalunya (2017), funds from the Pla Estratègic de Recerca i Innovacio en Salut (PERIS 2016¿2020), Projectes de recerca orientats al'atencio primària, SLT006/17/00345. This study has been funded by the Instituto de Salud Carlos III (ISCIII) through the projects 'PI20/00661 and PI24/00196' and co-funded by the European Union.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Relapse of first-episode schizophrenia patients and neurocognitive impairment: the role of dopaminergic and anticholinergic burden

  • Cuesta, Manuel J.
  • Ballesteros, Alejandro
  • Sánchez Torres, Ana María
  • Amoretti, Silvia
  • López-Ilundain, José M.
  • Merchán-Naranjo, Jessica
  • González-Ortega, Itxaso
  • Salgado, Purificación
  • Rodríguez-Jiménez, Roberto
  • Roldán-Bejarano, Alexandra
  • Sarró, Salvador
  • Ibáñez, Ángela
  • Usall, Judith
  • Escartí, Maria José
  • Moreno-Izco, Lucía
  • Mezquida, Gisela
  • Parellada, Mara
  • González Pinto, Ana
  • Berrocoso, Esther
  • Bernardo, Miguel
  • 2EPs Group
Background: the prevention of relapse may be a key factor to diminish the cognitive impairment of first-episode schizophrenia (FES) patients. We aimed to ascertain the effects of relapse, and dopaminergic and anticholinergic treatment burdens on cognitive functioning in the follow-up. Methods: ninety-nine FES patients participated in this study. Cognitive assessments were performed at baseline and after 3 years of follow-up or, in those patients who relapsed, after >2 months of stabilization of the new acute psychotic episode. The primary outcomes were final cognitive dimensions. Results: repeated measures MANOVA analyses showed improvements in the whole sample on the end-point assessments in processing speed and social cognition. However, only impairment in social cognition showed a significant interaction with relapse by time in this sample. Relapse in FES patients was significantly associated with poor performance on end-point assessments of working memory, social cognition and global cognitive score. Anticholinergic burden, but not dopaminergic burden, was associated with verbal memory impairment. These significant associations resulted after controlling for baseline cognitive functioning, relapse and dopaminergic burden. Conclusions: the relationship between relapse and cognitive impairment in recovered FES patients seems to be particularly complex at the short-term follow-up of these patients. While relapse was associated with working memory, social cognition impairments and global cognitive score, anticholinergic burden might play an additional worsening effect on verbal memory. Thus, tailoring or changing antipsychotics and other drugs to reduce their anticholinergic burden may be a potential modifiable factor to diminish cognitive impairment at this stage of the illness., We would also like to thank the Carlos III Healthcare Institute, the Spanish Ministry of Science, Innovation and Universities, the European Regional Development Fund (ERDF/FEDER) (PI08/0208, PI11/00325, PI14/00612); CIBERSAM; CERCA Program; Catalan Government, the Secretariat of Universities and Research of the Department of Enterprise and Knowledge (2017SGR1355) and Institut de Neurociències, Universitat de Barcelona. This work was supported by the Carlos III Health Institute (FEDER Funds) from the Spanish Ministry of Economy and Competitivity (08/01026, 11/02831, 14/01621 and 19/1698), and the Government of Navarra (18/41).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Sex differences in prolactin levels and clinical outcomes in patients with a first psychotic episode

  • Jordà-Baleri, Teresa
  • Garriga, Marina
  • Mezquida, Gisela
  • Cuesta, Manuel J.
  • Martínez-Aran, Anabel
  • García-Rizo, Clemente
  • Lobo, Antonio
  • González Pinto, Ana
  • Díaz-Caneja, Covadonga M.
  • Roldán, Alexandra
  • Vieta, Eduard
  • Baeza, Inmaculada
  • Trabsa, Amira
  • Montalvo, Itziar
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Verdolini, Norma
  • Ramos-Quiroga, Josep Antoni
  • Sánchez Torres, Ana María
  • Bernardo, Miguel
  • Amoretti, Silvia
  • PEPs Group
Aim: To analyze the clinical, neurocognitive, and functional impact of prolactin levels according to sex in patients with a First Episode Psychosis (FEP). Methods: We measured prolactin levels in 221 non-affective FEP patients treated with antipsychotics (AP) and 224 healthy controls, at baseline and 2-year follow-up. We examined whether the relationships between clinical and functional variables were mediated by prolactin, controlling for antipsychotic use, according to sex. Results: Prolactin levels were higher in patients when compared to controls at both time points. Baseline factors associated with prolactin were chlorpromazine equivalents, attention, and executive functioning. In the FEP group, prolactin levels were associated with functioning and diminished expression in males, and with working memory in females. Prolactin levels (p=0.0134) played a role as a mediator between negative symptomatology (p=0.086) and functional outcome (p=0.008) only in FEP male patients at baseline. Conclusions: Prolactin plays a role in the functionality and clinical symptomatology of FEP patients. Our results suggest that pharmacological counselling in patients with hyperprolactinemia at baseline and negative symptomatology might improve their functional and clinical outcomes., This study is part of a coordinated-multicentre Project, funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III -Fondo Europeo de Desarrollo Regional. Unión Europea. Una manera de hacer Europa, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, by the CERCA Programme / Generalitat de Catalunya AND Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2021SGR 01120). This work was supported by La Marató-TV3 Foundation grants 202234-30 (to E. Vieta), 202234-32 (to S. Amoretti) and 202205-10 (to M. Bernardo).
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

The polygenic basis of relapse after a first episode of schizophrenia

  • Segura, A.G.
  • Prohens, Llucia
  • Gassó, P.
  • Rodríguez, N.
  • Garcia-Rizo, C.
  • Moreno-Izco, Lucia
  • Andreu-Bernabeu, A.
  • Zorrilla, I.
  • Mane, A.
  • Rodriguez-Jimenez, R.
  • Roldán, A.
  • Sarró, S.
  • Ibáñez, A.
  • Usall, J.
  • Sáiz, P.A.
  • Cuesta, M.J.
  • Parellada, M.
  • González-Pinto, Ana
  • Berrocoso Domínguez, Esther María
  • Bernardo, M.
  • Mas, S.
  • Mezquida, G.
  • Arbelo, N.
  • De Matteis, M.
  • Galvañ, J.
  • Duque Guerra, A.
  • Arias i Queralt, L.
  • Perez-Bacigalupe, M.
  • Gonzalez-Ortega, I
  • Toll, A.
  • Casanovas, F.
  • Sanchez-Pastor, L.
  • Valtueña, M.
  • Pomarol-Clotet, Edit
  • García-León, M.A.
  • Butjosa, A.
  • Rubio-Abadal, E.
  • Ribeiro, M.
  • López-Ilundain, J.M.
  • Saiz-Ruiz, J.
  • León-Quismondo, L.
  • Rivero, O.
  • Ruiz, P.
  • Echevarría, R.S.
  • García Portilla, María Paz
Little is known about genetic predisposition to relapse. Previous studies have linked cognitive and psychopathological (mainly schizophrenia and bipolar disorder) polygenic risk scores (PRS) with clinical manifestations of the disease. This study aims to explore the potential role of PRS from major mental disorders and cognition on schizophrenia relapse. 114 patients recruited in the 2EPs Project were included (56 patients who had not experienced relapse after 3 years of enrollment and 58 patients who relapsed during the 3-year follow-up). PRS for schizophrenia (PRS-SZ), bipolar disorder (PRS-BD), education attainment (PRS-EA) and cognitive performance (PRS-CP) were used to assess the genetic risk of schizophrenia relapse.Patients with higher PRS-EA, showed both a lower risk (OR=0.29, 95% CI [0.11–0.73]) and a later onset of relapse (30.96± 1.74 vs. 23.12± 1.14 months, p=0.007. Our study provides evidence that the genetic burden of neurocognitive function is a potentially predictors of relapse that could be incorporated into future risk prediction models. Moreover, appropriate treatments for cognitive symptoms appear to be important for improving the long-term clinical outcome of relapse.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients

  • Rodríguez, Natalia
  • Gassó, P.
  • Martínez-Pinteño, A.
  • González Segura, Álex
  • Mezquida, G.
  • Moreno-Izco, Lucia
  • González-Peñas, J.
  • Zorrilla, Iñaki
  • Martin, Marta
  • Rodriguez-Jimenez, R.
  • Corripio, I.
  • Sarró, S.
  • Ibáñez, A.
  • Butjosa, Anna
  • Contreras, Fernando
  • Bioque, Miquel
  • Cuesta, Manuel Jesús
  • Parellada, M.
  • González-Pinto, A.
  • Berrocoso Domínguez, Esther María
  • Bernardo, Miquel
  • Mas, Sergi
  • 2EPS group
A better understanding of schizophrenia subtypes is necessary to stratify the patients according to clinical attributes. To explore the genomic architecture of schizophrenia symptomatology, we analyzed blood co-expression modules and their association with clinical data from patients in remission after a first episode of schizophrenia. In total, 91 participants of the 2EPS project were included. Gene expression was assessed using the Clariom S Human Array. Weighted-gene co-expression network analysis (WGCNA) was applied to identify modules of co-expressed genes and to test its correlation with global functioning, clinical symptomatology, and premorbid adjustment. Among the 25 modules identified, six modules were significantly correlated with clinical data. These modules could be clustered in two groups according to their correlation with clinical data. Hub genes in each group showing overlap with risk genes for schizophrenia were enriched in biological processes related to metabolic processes, regulation of gene expression, cellular localization and protein transport, immune processes, and neurotrophin pathways. Our results indicate that modules with significant associations with clinical data showed overlap with gene sets previously identified in differential gene-expression analysis in brain, indicating that peripheral tissues could reveal pathogenic mechanisms. Hub genes involved in these modules revealed multiple signaling pathways previously related to schizophrenia, which may represent the complex interplay in the pathological mechanisms behind the disease. These genes could represent potential targets for the development of peripheral biomarkers underlying illness traits in clinical remission stages after a first episode of schizophrenia.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A pharmacovigilance study in first episode of psychosis: Psychopharmacological interventions and safety profiles in the peps project

  • Bioque, M.
  • Llerena, A.
  • Cabrera, B.
  • Mezquida, G.
  • Lobo, A.
  • González-Pinto, A.
  • Díaz-Caneja, C.M.
  • Corripio, I.
  • Aguilar, E.J.
  • Bulbena, A.
  • Castro-Fornieles, J.
  • Vieta, E.
  • Lafuente, A.
  • Mas, S.
  • Parellada, M.
  • Saiz-Ruiz, J.
  • Cuesta, M.J.
  • Bernardo, M.
  • Gassó, P.
  • Amoretti, S.
  • García Bernardo, E.
  • Tapia-Casellas, C.
  • Alonso-Solís, A.
  • Grasa, E.
  • Hernández, M.
  • González, I.
  • Ruiz, P.
  • Modrego, F.
  • Escartí, M.J.
  • Mané, A.
  • Torrent, C.
  • Baeza, I.
  • Contreras, F.
  • Albacete, A.
  • Bobes, J.
  • García-Portilla, Ma P.
  • Zabala Rabadán, A.
  • Segarra Echevarría, R.
  • Rodriguez-Jimenez, R.
  • Morales-Muñoz, I.
  • Butjosa, A.
  • Landin-Romero, R.
  • Sarró, S.
  • Ibáñez, Á.
  • Sánchez-Torres, A.Ma
  • Balanzá-Martínez, V.
Background: The characterization of the first episode of psychosis and how it should be treated are principal issues in actual research. Realistic, naturalistic studies are necessary to represent the entire population of first episode of psychosis attended in daily practice. Methods: Sixteen participating centers from the PEPs project recruited 335 first episode of psychosis patients, aged 7 to 35 years. This article describes and discusses the psychopharmacological interventions and safety profiles at baseline and during a 60-day pharmacovigilance period. Results: The majority of first episode of psychosis patients received a second-generation antipsychotic (96.3%), orally (95%), and in adjusted doses according to the product specifications (87.2%). A total of 24% were receiving an antipsychotic polytherapy pattern at baseline, frequently associated with lower or higher doses of antipsychotics than the recommended ones. Eight patients were taking clozapine, all in monotherapy. Males received higher doses of antipsychotic (P=.043). A total of 5.2% of the patients were being treated with long-acting injectable antipsychotics; 12.2% of the patients received anticholinergic drugs, 12.2% antidepressants, and 13.7% mood stabilizers, while almost 40% received benzodiazepines; and 35.52% reported at least one adverse drug reaction during the pharmacovigilance period, more frequently associated with higher antipsychotic doses and antipsychotic polytherapy (85.2% vs 45.5%, P<.001). Conclusions: These data indicate that the overall pharmacologic prescription for treating a first episode of psychosis in Spain follows the clinical practice guideline recommendations, and, together with security issues, support future research of determinate pharmacological strategies for the treatment of early phases of psychosis, such as the role of clozapine, long-acting injectable antipsychotics, antipsychotic combination, and the use of benzodiazepines.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Opposite cannabis-cognition associations in psychotic patients depending on family history

  • González-Pinto, A.
  • González-Ortega, I.
  • Alberich, S.
  • De Azúa, S.R.
  • Bernardo, M.
  • Bioque, M.
  • Cabrera, B.
  • Corripio, I.
  • Arango, C.
  • Lobo, A.
  • Sánchez-Torres, A.M.
  • Cuesta, M.J.
  • Ugarte, A.
  • Fernández, M.
  • Mezquida, G.
  • Meseguer, A.
  • Vieta, E.
  • Torrent, C.
  • Contreras, F.
  • Albacete, A.
  • Alonso-Solís, A.
  • Rabella, M.
  • Moreno-Izco, L.
  • Usall, J.
  • Butjosa, A.
  • Ibáñez, Á.
  • Bobes, J.
  • Al-Halabí, S.
  • Zapata-Usábel, M.T.
  • Laporta-Herrero, I.
  • Balanzá-Martínez, V.
  • Bergé, D.
  • Mané, A.
  • Rodriguez-Jimenez, R.
  • Morales-Muñoz, I.
  • Gutierrez, M.
  • Zabala, A.
  • Sarró, S.
  • Landin-Romero, R.
  • Serna, De La
  • Baeza, I.
  • Parellada, M.
  • Espliego, A.
  • Juan, J.S.
  • Aguilar, E.
The objective of this study is to investigate cognitive performance in a first-episode psychosis sample, when stratifying the interaction by cannabis use and familial or non-familial psychosis. Hierarchical-regression models were used to analyse this association in a sample of 268 first-episode psychosis patients and 237 controls. We found that cannabis use was associated with worse working memory, regardless of family history. However, cannabis use was clearly associated with worse cognitive performance in patients with no family history of psychosis, in cognitive domains including verbal memory, executive function and global cognitive index, whereas cannabis users with a family history of psychosis performed better in these domains. The main finding of the study is that there is an interaction between cannabis use and a family history of psychosis in the areas of verbal memory, executive function and global cognition: that is, cannabis use is associated with a better performance in patients with a family history of psychosis and a worse performance in those with no family history of psychosis. In order to confirm this hypothesis, future research should explore the actual expression of the endocannabinoid system in patients with and without a family history of psychosis.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique

  • Amoretti, S.
  • Verdolini, N.
  • Mezquida, G.
  • Rabelo-da-Ponte, F.D.
  • Cuesta, M.J.
  • Pina-Camacho, L.
  • Gomez-Ramiro, M.
  • De-la-Cámara, C.
  • González-Pinto, A.
  • Díaz-Caneja, C.M.
  • Corripio, I.
  • Vieta, E.
  • de la Serna, E.
  • Mané, A.
  • Solé, B.
  • Carvalho, A.F.
  • Serra, M.
  • Bernardo, M.
The extreme variability in symptom presentation reveals that individuals diagnosed with a first-episode psychosis (FEP) may encompass different sub-populations with potentially different illness courses and, hence, different treatment needs. Previous studies have shown that sociodemographic and family environment factors are associated with more unfavorable symptom trajectories. The aim of this study was to examine the dimensional structure of symptoms and to identify individuals’ trajectories at early stage of illness and potential risk factors associated with poor outcomes at follow-up in non-affective FEP. One hundred and forty-four non-affective FEP patients were assessed at baseline and at 2-year follow-up. A Principal component analysis has been conducted to identify dimensions, then an unsupervised machine learning technique (fuzzy clustering) was performed to identify clinical subgroups of patients. Six symptom factors were extracted (positive, negative, depressive, anxiety, disorganization and somatic/cognitive). Three distinct clinical clusters were determined at baseline: mild; negative and moderate; and positive and severe symptoms, and five at follow-up: minimal; mild; moderate; negative and depressive; and severe symptoms. Receiving a low-dose antipsychotic, having a more severe depressive symptomatology and a positive family history for psychiatric disorders were risk factors for poor recovery, whilst having a high cognitive reserve and better premorbid adjustment may confer a better prognosis. The current study provided a better understanding of the heterogeneous profile of FEP. Early identification of patients who could likely present poor outcomes may be an initial step for the development of targeted interventions to improve illness trajectories and preserve psychosocial functioning.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients

  • Rodriguez, Natalia
  • Gasso, Patricia
  • Martinez-Pinteno, Albert
  • Segura, Alex-Gonzalez
  • Mezquida, Gisela
  • Moreno-Izco, Lucia
  • Gonzalez-Penas, Javier
  • Zorrilla, Inaki
  • Martin, Marta
  • Rodriguez-Jimenez, Roberto
  • Corripio, Iluminada
  • Sarro, Salvador
  • Ibanez, Angela
  • Butjosa, Anna
  • Contreras, Fernando
  • Bioque, Miquel
  • Cuesta, Manuel-Jesus
  • Parellada, Mara
  • Gonzalez-Pinto, Ana
  • Berrocoso, Esther
  • Bernardo, Miquel
  • Mas, Sergi
  • Silvia Amoretti, S.
  • Moren, Constanza
  • Stella, Carol
  • Gurriaran, Xaquin
  • Alonso-Solis, Anna
  • Grasa, Eva
  • Fernandez, Jessica
  • Gonzalez-Ortega, Itxaso
  • Casanovas, Francesc
  • Bulbuena, Antoni
  • Nunez-Doyle, Agatha
  • Jimenez-Rodriguez, Olga
  • Pomarol-Clotet, Edith
  • Feria-Raposo, Isabel
  • Usall, Judith
  • Munoz-Samons, Daniel
  • Ilundain, Jose L.
  • Maria Sanchez-Torres, Ana
  • Saiz-Ruiz, Jeronimo
  • Lopez-Torres, Isabel
  • Nacher, Juan
  • De la Camara Izquierdo, Concepcion
  • Gutierrez, Miguel
  • Alejandra Saiz, Pilar
A better understanding of schizophrenia subtypes is necessary to stratify the patients according to clinical attributes. To explore the genomic architecture of schizophrenia symptomatology, we analyzed blood co-expression modules and their association with clinical data from patients in remission after a first episode of schizophrenia. In total, 91 participants of the 2EPS project were included. Gene expression was assessed using the Clariom S Human Array. Weighted-gene co-expression network analysis (WGCNA) was applied to identify modules of co-expressed genes and to test its correlation with global functioning, clinical symptomatology, and premorbid adjustment. Among the 25 modules identified, six modules were significantly correlated with clinical data. These modules could be clustered in two groups according to their correlation with clinical data. Hub genes in each group showing overlap with risk genes for schizophrenia were enriched in biological processes related to metabolic processes, regulation of gene expression, cellular localization and protein transport, immune processes, and neurotrophin pathways. Our results indicate that modules with significant associations with clinical data showed overlap with gene sets previously identified in differential gene-expression analysis in brain, indicating that peripheral tissues could reveal pathogenic mechanisms. Hub genes involved in these modules revealed multiple signaling pathways previously related to schizophrenia, which may represent the complex interplay in the pathological mechanisms behind the disease. These genes could represent potential targets for the development of peripheral biomarkers underlying illness traits in clinical remission stages after a first episode of schizophrenia.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Epigenetic clocks in relapse after a first episode of schizophrenia

  • Segura, Àlex-González
  • Prohens, Llucia
  • Mezquida, Gisela
  • Amoretti, Silvia
  • Bioque, Miquel
  • Ribeiro, María
  • Gurriarán-Bas, Xaquin
  • Rementería, Lide
  • Berge, Daniel
  • Rodriguez-Jimenez, Roberto
  • Roldán, Alexandra
  • Pomarol-Clotet, Edith
  • Ibáñez, Angela
  • Usall, Judith
  • García-Portilla, Maria Paz
  • Cuesta, Manuel J.
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Esther
  • Bernardo, Miquel
  • Mas, Sergi
  • González-Díaz, Jairo M.
  • Arbelo, Néstor
  • González-Peñas, Javier
  • Pina-Camacho, Laura
  • Diestre, Alba
  • Selma, Judit
  • Zorrilla, Iñaki
  • López, Purificación
  • Trabsa, Amira
  • Monserrat, Clara
  • Sanchez-Pastor, Luis
  • Nuñez-Doyle, Aggie
  • Fatjó-Vilas, Mar
  • Sarró, Salvador
  • Butjosa, Anna
  • Pardo, Marta
  • López-Ilundain, Jose M.
  • Sánchez Torres, Ana M.
  • Saiz-Ruiz, Jerónimo
  • Ochoa-Mangado, Enriqueta
  • RIevero, Olga
  • De la Cámara, Concepción
  • Segarra Echevarría, Rafael
  • González-Blanco, Leticia
The main objective of the present study was to investigate the association between several epigenetic clocks, covering different aspects of aging, with schizophrenia relapse evaluated over a 3-year follow-up period in a cohort of ninety-one first-episode schizophrenia patients. Genome-wide DNA methylation was profiled and four epigenetic clocks, including epigenetic clocks of chronological age, mortality and telomere length were calculated. Patients that relapsed during the follow-up showed epigenetic acceleration of the telomere length clock (p = 0.030). Shorter telomere length was associated with cognitive performance (working memory, r = 0.31 p = 0.015; verbal fluency, r = 0.28 p = 0.028), but no direct effect of cognitive function or symptom severity on relapse was detected. The results of the present study suggest that epigenetic age acceleration could be involved in the clinical course of schizophrenia and could be a useful marker of relapse when measured in remission stages.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis

  • Solanes, Aleix
  • Mezquida, Gisela
  • Janssen, Joost
  • Amoretti, Silvia
  • Lobo, Antonio
  • González-Pinto, Ana
  • Arango, Celso
  • Vieta, Eduard
  • Castro-Fornieles, Josefina
  • Bergé, Daniel
  • Albacete, Auria
  • Giné, Eloi
  • Parellada, Mara
  • Bernardo, Miguel
  • Bioque, Miquel
  • Morén, Constanza
  • Pina-Camacho, Laura
  • Díaz-Caneja, Covadonga M.
  • Zorrilla, Iñaki
  • Corres, Edurne Garcia
  • De-La-Camara, Concepción
  • Barcones, Fe
  • Escarti, María José
  • Aguilar, Eduardo Jesus
  • Legido, Teresa
  • Martin, Marta
  • Verdolini, Norma
  • Martinez-Aran, Anabel
  • Baeza, Immaculada
  • de la Serna, Elena
  • Contreras, Fernando
  • Bobes, Julio
  • García-Portilla, María Paz
  • Sanchez-Pastor, Luis
  • Rodriguez-Jimenez, Roberto
  • Usall, Judith
  • Butjosa, Anna
  • Salgado-Pineda, Pilar
  • Salvador, Raymond
  • Pomarol-Clotet, Edith
  • Radua, Joaquim
Detecting patients at high relapse risk after the first episode of psychosis (HRR-FEP) could help the clinician adjust the preventive treatment. To develop a tool to detect patients at HRR using their baseline clinical and structural MRI, we followed 227 patients with FEP for 18–24 months and applied MRIPredict. We previously optimized the MRI-based machine-learning parameters (combining unmodulated and modulated gray and white matter and using voxel-based ensemble) in two independent datasets. Patients estimated to be at HRR-FEP showed a substantially increased risk of relapse (hazard ratio = 4.58, P < 0.05). Accuracy was poorer when we only used clinical or MRI data. We thus show the potential of combining clinical and MRI data to detect which individuals are more likely to relapse, who may benefit from increased frequency of visits, and which are unlikely, who may be currently receiving unnecessary prophylactic treatments. We also provide an updated version of the MRIPredict software.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The effect of early life events on glucose levels in first-episode psychosis

  • Garcia-Rizo, Clemente
  • Cabrera, Bibiana
  • Bioque, Miquel
  • Mezquida, Gisela
  • Lobo, Antonio
  • Gonzalez-Pinto, Ana
  • Diaz-Caneja, Covadonga M.
  • Corripio, Iluminada
  • Vieta, Eduard
  • Baeza, Inmaculada
  • Garcia-Portilla, Maria Paz
  • Gutierrez-Fraile, Miguel
  • Rodriguez-Jimenez, Roberto
  • Garriga, Marina
  • Fernandez-Egea, Emilio
  • Bernardo, Miguel
  • PEPs Group
First episode of psychosis (FEP) patients display a wide variety of metabolic disturbances at onset, which might underlie these patients’ increased morbidity and early mortality. Glycemic abnormalities have been previously related to pharmacological agents; however, recent research highlights the impact of early life events. Birth weight (BW), an indirect marker of the fetal environment, has been related to glucose abnormalities in the general population over time. We aim to evaluate if BW correlates with glucose values in a sample of FEP patients treated with different antipsychotics. Two hundred and thirty-six patients were included and evaluated for clinical and metabolic variables at baseline and at 2, 6, 12, and 24 months of follow-up. Pearson correlations and linear mixed model analysis were conducted to analyze the data. Antipsychotic treatment was grouped due to its metabolic risk profile. In our sample of FEP patients, BW was negatively correlated with glucose values at 24 months of follow-up [r=-0.167, p=0.037]. BW showed a trend towards significance in the association with glucose values over the 24-month period (F=3.22; p=0.073) despite other confounders such as age, time, sex, body mass index, antipsychotic type, and chlorpromazine dosage. This finding suggests that BW is involved in the evolution of glucose values over time in a cohort of patients with an FEP, independently of the type of pharmacological agent used in treatment. Our results highlight the importance of early life events in the later metabolic outcome of patients.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Cortical thinning over two years after first-episode psychosis depends on age of onset

  • Pina-Camacho, Laura
  • Martinez, Kenia
  • Diaz-Caneja, Covadonga M.
  • Mezquida, Gisela
  • Cuesta, Manuel J.
  • Moreno, Carmen
  • Amoretti, Silvia
  • González-Pinto, Ana
  • Arango, Celso
  • Vieta, Eduard
  • Castro-Fornieles, Josefina
  • Lobo, Antonio
  • Fraguas, David
  • Bernardo, Miguel
  • Janssen, Joost
  • Parellada, Mara
  • Madero, Santiago
  • Gómez-Ramiro, Marta
  • Rodriguez-Toscano, Elisa
  • Santonja, Javier
  • Zorrilla, Iñaki
  • González-Ortega, Itxaso
  • Fayed, Nicolás
  • Santabárbara, Javier
  • Berge, Daniel
  • Toll, Alba
  • Nacher, Juan
  • García Martí, Gracián
  • Sague-Vilavella, Maria
  • Sanchez-Moreno, Jose
  • de la Serna, Elena
  • Baeza, Immaculada
  • Saiz-Masvidal, Cristina
  • Contreras, Fernando
  • González-Blanco, Leticia
  • Bobes-Bascarán, Teresa
  • Dompablo, Mónica
  • Rodriguez-Jimenez, Roberto
  • Usall, Judith
  • Butjosa, Anna
  • Pomarol-Clotet, Edith
  • Sarró, Salvador
First-episode psychosis (FEP) patients show structural brain abnormalities at the first episode. Whether the cortical changes that follow a FEP are progressive and whether age at onset modulates these changes remains unclear. This is a multicenter MRI study in a deeply phenotyped sample of 74 FEP patients with a wide age range at onset (15–35 years) and 64 neurotypical healthy controls (HC). All participants underwent two MRI scans with a 2-year follow-up interval. We computed the longitudinal percentage of change (PC) for cortical thickness (CT), surface area (CSA) and volume (CV) for frontal, temporal, parietal and occipital lobes. We used general linear models to assess group differences in PC as a function of age at FEP. We conducted post-hoc analyses for metrics where PC differed as a function of age at onset. We found a significant age-by-diagnosis interaction effect for PC of temporal lobe CT (d = 0.54; p = 002). In a post-hoc-analysis, adolescent-onset (≤19 y) FEP showed more severe longitudinal cortical thinning in the temporal lobe than adolescent HC. We did not find this difference in adult-onset FEP compared to adult HC. Our study suggests that, in individuals with psychosis, CT changes that follow the FEP are dependent on the age at first episode, with those with an earlier onset showing more pronounced cortical thinning in the temporal lobe.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis

  • Valli, Isabel
  • Gonzalez Segura, Alex
  • Verdolini, Norma
  • Garcia-Rizo, Clemente
  • Berge, Daniel
  • Baeza, Inmaculada
  • Cuesta, Manuel J.
  • Gonzalez-Pinto, Ana
  • Lobo, Antonio
  • Martinez-Aran, Anabel
  • Mezquida, Gisela
  • Pina-Camacho, Laura
  • Roldan Bejarano, Alexandra
  • Mas, Sergi
  • McGuire, Philip
  • Bernardo, Miquel
  • Vieta, Eduard
Background: Obstetric complications (OCs) are key contributors to psychosis risk. However, it is unclear whether they increase psychosis vulnerability independently of genetic risk, in interaction with it, or are a manifestation of psychosis proneness. We examined the role of distinct types of OCs in terms of psychosis risk and tested whether they interact differently with genetic vulnerability, whilst accounting for other known environmental risk factors. Study Design: 405 participants (219 first episode psychosis patients and 186 healthy volunteers) underwent a comprehensive assessment of OCs, measured using the Lewis-Murray scale and divided into complications of pregnancy, abnormalities of foetal growth and development, and complications of delivery. Participants were compared in terms of history of OCs, polygenic risk score for schizophrenia (PRS-SZ) and interactions between these. Results: Both complications of pregnancy and abnormalities of foetal growth were significantly associated with case–control status (p = 0.02 and 0.03, respectively), whereas complications of delivery were not. PRS-SZ showed a significant association with psychosis (p = 0.04), but there were no significant interactions between genetic risk for schizophrenia and OCs, either when these were considered globally or separated based on their timeframe. Conclusions: We observed no significant interaction between genetic and obstetric vulnerability, yet distinct types of OCs may have a different impact on psychosis risk, based on their nature and timeframe. Examining their differential role might clarify their relative contributions to this risk.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults

  • De la Serna, E.
  • Puig, O.
  • Mezquida, G.
  • Moreno-Izco, L.
  • Merchan-Naranjo, J.
  • Amoretti, S.
  • Ruiz Lázaro, P.
  • Gonzalez-Pinto, A.
  • Molina-Garcia, M.
  • Corripio, I.
  • Vieta, E.
  • Baeza, I.
  • Berge, D.
  • Penades, R.
  • Sanchez-Torres, A.
  • Cuesta, M.J.
  • Bernardo, M.
  • Castro-Fornieles, J.
Psychotic disorders typically manifest from late adolescence to early adulthood, and an earlier onset might be associated with greater symptom severity and a worse long-term prognosis. This study aimed to compare the cognitive characteristics of patients with first-episode psychosis (FEP) by their age at onset. We included 298 patients diagnosed with FEP and classified them as having an early onset (EOS), youth onset (YOS), or adult onset (AOS) based on age limits of <= 18 years (N = 61), 19-24 years (N = 121), and >= 25 years (N = 116), respectively. Socio-demographic and clinical variables included age at baseline, gender, socio-economic status, antipsychotic medication, DSM-IV diagnoses assessed by clinical semi-structured interview, psychotic symptom severity, and age at onset. Neuropsychological assessment included six cognitive domains: premorbid intelligence, working memory, processing speed, verbal memory, sustained attention, and executive functioning. The EOS group had lower scores than the YOS or AOS groups in global cognition, executive functioning, and sustained attention. Although the scores in the YOS group were intermediate to those in the EOS and AOS groups for most cognitive factors, no statistically significant differences were detected between the YOS and AOS groups. Age at onset results in specific patterns of cognitive interference. Of note, impairment appears to be greater with EOS samples than with either YOS or AOS samples. A longitudinal study with a larger sample size is needed to confirm our findings.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort

  • Segura, A. G
  • Mané, A.
  • Prohens, Ll.
  • Rodríguez, N.
  • Mezquida, G.
  • Cuesta, M. J
  • Vieta, E.
  • Amoretti, S.
  • Lobo, A.
  • González-Pinto, A.
  • Díaz-Caneja, C. M.
  • Roldán Bejarano, A.
  • Jiménez, E.
  • Baeza, I.
  • Legido, T.
  • Saiz-Ruiz, J.
  • Bernardo, M.
  • Mas, S.
  • PEPs Group
Cannabis use is highly prevalent in first-episode psychosis (FEP) and plays a critical role in its onset and prognosis, but the genetic underpinnings promoting both conditions are poorly understood. Current treatment strategies for cannabis cessation in FEP are clearly inefficacious. Here, we aimed to characterize the association between cannabis-related polygenic risk scores (PRS) on cannabis use and clinical course after a FEP. A cohort of 249 FEP individuals were evaluated during 12 months. Symptom severity was measured with the Positive and Negative Severity Scale and cannabis use with the EuropASI scale. Individual PRS for lifetime cannabis initiation (PRSCI) and cannabis use disorder (PRSCUD) were constructed. Current cannabis use was associated with increased positive symptoms. Cannabis initiation at younger ages conditioned the 12-month symptom progression. FEP patients with higher cannabis PRSCUD reported increased baseline cannabis use. PRSCI was associated with the course of negative and general symptomatology over follow-up. Cannabis use and symptom progression after a FEP were modulated by cannabis PRS, suggesting that lifetime initiation and use disorders may have partially independent genetic factors. These exploratory results may be the first step to identify those FEP patients more vulnerable to cannabis use and worse outcomes to ultimately develop tailored treatments.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Obstetric complications and clinical presentation in first episode of psychosis

  • Verdolini, N.
  • Mezquida, G.
  • Valli, I.
  • García-Rizo, C.
  • Cuesta, M.
  • Vieta, E.
  • Bioque, M.
  • Lobo, A.
  • González-Pinto, A.
  • Pina-Camacho, L.
  • Corripio, I.
  • Garriga, M.
  • Baeza, I.
  • Martínez-Sadurní, L.
  • Bitanihirwe, B.
  • Cannon, M.
  • Bernardo, M.
  • De la Cámara, C.
  • Ruiz-Lázaro, P. M.
  • PEPs Group
Objective: Psychotic disorders exhibit a complex aetiology that combines genetic and environmental factors. Among the latter, obstetric complications (OCs) have been widely studied as risk factors, but it is not yet well understood how OCs relate to the heterogeneous presentations of psychotic disorders. We assessed the clinical phenotypes of individuals with a first episode of psychosis (FEP) in relation to the presence of OCs. Methods: Two-hundred seventy-seven patients with an FEP were assessed for OCs using the Lewis–Murray scale, with data stratified into three subscales depending on the timing and the characteristics of the obstetric event, namely: complications of pregnancy, abnormal foetal growth and development and difficulties in delivery. We also considered other two groups: any complications during the pregnancy period and all OCs taken altogether. Patients were clinically evaluated with the Positive and Negative Syndrome Scale for schizophrenia. Results: Total OCs and difficulties in delivery were related to more severe psychopathology, and this remained significant after co-varying for age, sex, traumatic experiences, antipsychotic dosage and cannabis use. Conclusions: Our results highlight the relevance of OCs for the clinical presentation of psychosis. Describing the timing of the OCs is essential in understanding the heterogeneity of the clinical presentation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode

  • Segura, Alex G.
  • Mezquida, Gisela
  • Martínez-Pinteño, Albert
  • Gassó, Patricia
  • Rodriguez, Natalia
  • Moreno-Izco, Lucía
  • Amoretti, Silvia
  • Bioque, Miquel
  • Lobo, Antonio
  • González-Pinto, Ana
  • García-Alcon, Alicia
  • Roldán-Bejarano, Alexandra
  • Vieta, Eduard
  • de la Serna, Elena
  • Toll, Alba
  • Cuesta, Manuel J.
  • Mas, Sergi
  • Bernardo, Miquel
Background Clinical intervention in early stages of psychotic disorders is crucial for the prevention of severe symptomatology trajectories and poor outcomes. Genetic variability is studied as a promising modulator of prognosis, thus novel approaches considering the polygenic nature of these complex phenotypes are required to unravel the mechanisms underlying the early progression of the disorder. Methods The sample comprised of 233 first-episode psychosis (FEP) subjects with clinical and cognitive data assessed periodically for a 2-year period and 150 matched controls. Polygenic risk scores (PRSs) for schizophrenia, bipolar disorder, depression, education attainment and cognitive performance were used to assess the genetic risk of FEP and to characterize their association with premorbid, baseline and progression of clinical and cognitive status. Results Schizophrenia, bipolar disorder and cognitive performance PRSs were associated with an increased risk of FEP [false discovery rate (FDR) ⩽ 0.027]. In FEP patients, increased cognitive PRSs were found for FEP patients with more cognitive reserve (FDR ⩽ 0.037). PRSs reflecting a genetic liability for improved cognition were associated with a better course of symptoms, functionality and working memory (FDR ⩽ 0.039). Moreover, the PRS of depression was associated with a worse trajectory of the executive function and the general cognitive status (FDR ⩽ 0.001). Conclusions Our study provides novel evidence of the polygenic bases of psychosis and its clinical manifestation in its first stage. The consistent effect of cognitive PRSs on the early clinical progression suggests that the mechanisms underlying the psychotic episode and its severity could be partially independent.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The polygenic basis of relapse after a first episode of schizophrenia

  • González Segura, Àlex
  • Prohens, Llucia
  • Gassó, Patricia
  • Rodríguez, Natalia
  • Garcia-Rizo, Clemente
  • Moreno-Izco, Lucía
  • Andreu-Bernabeu, Álvaro
  • Zorrilla, Iñaki
  • Mane, Anna
  • Rodríguez-Jiménez, Roberto
  • Roldán, Alexandra
  • Sarró, Salvador
  • Ibáñez, Ángela
  • Usall, Judith
  • Sáiz, Pilar A
  • Cuesta, Manuel J.
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Ester
  • Bernardo, Miquel
  • Mas, Sergi
  • Mezquida, Gisela
  • Arbelo, Néstor
  • De Matteis, Mario
  • Galvañ, Joaquín
  • Duque Guerra, Alejandra
  • Arias i Queralt, Laia
  • Perez-Bacigalupe, Maria
  • Gonzalez-Ortega, Itxaso
  • Toll, Alba
  • Casanovas, Francesc
  • Sanchez-Pastor, Luis
  • Valtueña, Mercedes
  • Pomarol-Clotet, Edith
  • García-León, Maria Ángeles
  • Butjosa, Ana
  • Rubio-Abadal, Elena
  • Ribeiro, María
  • López-Ilundain, Jose M.
  • Saiz-Ruiz, Jeronimo
  • León-Quismondo, Luis
  • Rivero, Olga
  • Ruiz, Pedro
  • Echevarría, Rafael Segarra
  • García-Portilla, M. Paz
Little is known about genetic predisposition to relapse. Previous studies have linked cognitive and psychopathological (mainly schizophrenia and bipolar disorder) polygenic risk scores (PRS) with clinical manifestations of the disease. This study aims to explore the potential role of PRS from major mental disorders and cognition on schizophrenia relapse. 114 patients recruited in the 2EPs Project were included (56 patients who had not experienced relapse after 3 years of enrollment and 58 patients who relapsed during the 3-year follow-up). PRS for schizophrenia (PRS-SZ), bipolar disorder (PRS-BD), education attainment (PRS-EA) and cognitive performance (PRS-CP) were used to assess the genetic risk of schizophrenia relapse.Patients with higher PRS-EA, showed both a lower risk (OR=0.29, 95% CI [0.11–0.73]) and a later onset of relapse (30.96± 1.74 vs. 23.12± 1.14 months, p=0.007. Our study provides evidence that the genetic burden of neurocognitive function is a potentially predictors of relapse that could be incorporated into future risk prediction models. Moreover, appropriate treatments for cognitive symptoms appear to be important for improving the long-term clinical outcome of relapse.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: a mediation analysis

  • Clougher, Derek
  • G Segura, Àlex
  • Forte, María Florencia
  • Mezquida, Gisela
  • Cuesta, Manuel J.
  • Vieta, Eduard
  • Amoretti, Silvia
  • Lobo, Antonio
  • González-Pinto, Ana
  • M. Díaz-Caneja, Covadonga
  • Roldán, Alexandra
  • Fico, Giovanna
  • de la Serna, Elena
  • Bergé, Daniel
  • Gassó, Patricia
  • Rodriguez, Natalia
  • Verdolini, Norma
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ribasés, Marta
  • Bernardo, Miguel
  • Mas, Sergi
Background: Polygenic risk scores for educational attainment (PRSEA), cognitive reserve (CR), and clinical symptoms are associated with psychosocial functioning in first-episode psychosis (FEP). Nevertheless, the mechanisms underlying their complex interaction is yet to be explored. This study aimed to assess the mediating role of CR and clinical symptoms, both negative (NS) and positive (PS), on the interrelationship between PRSEA and functionality, one year after a FEP. Methods: A total of 162 FEP patients underwent clinical, functional, and genetic assessments. Using genome-wide association study (GWAS) summary results, PRSEA were constructed for each individual. Two mediation models were explored. The parallel mediation model explored the relationship of PRSEA with functionality through CR and clinical symptoms, NS, and PS. The serial mediation model tested a causal chain of the three mediators: CR, NS and PS. Mediation analysis was performed using the PROCESS function V.4.1 in SPSS V.22. Results: A serial mediation model revealed a causal chain for PRSEA > CR > NS > Functionality (β=-0.35, 95%CI [-0.85, -0.04], p<0.05). The model fit the data satisfactorily (CFI=1.00; RMSEA=0.00; SRMR=7.2x10-7). Conversely, in a parallel mediation, none of the three mediators significantly mediated the relationship between PRSEA and functionality and the model poorly fit the data (CFI=0.30; RMSEA=0.25; SRMR=0.11). Conclusions: Both CR and NS mediate the relationship between PRSEA and functionality at oneyear follow-up, using serial mediation analysis. This may be relevant for prevention and personalized early intervention to reduce illness impact and improve functional outcomes in FEP patients.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

  • Bioque, Miquel
  • Llorca-Bofí, Vicent
  • Salmerón, Sergi
  • García-Bueno, Borja
  • MacDowell, Karina S.
  • Moreno, Carmen
  • Sáiz, Pilar A.
  • González-Pinto, Ana
  • Hidalgo-Figueroa, María
  • Barcones, María Fe
  • Rodriguez-Jimenez, Roberto
  • Bernardo, Miquel
  • Leza, Juan Carlos
Neutrophil to lymphocyte ratio (NLR) has been proposed as an emerging marker of the immune system alterations in psychotic disorders. However, it is not entirely clear whether NLR elevation is a characteristic of the psychotic disorder itself, which inflammatory pathways activation is detecting, or which possible confounding variables could alter its interpretation. We aimed to analyze the relationship of NLR values with a panel of inflammatory and oxidative/nitrosative stress biomarkers and main potential confounding factors in a well-characterized cohort of 97 patients with a first episode of psychosis (FEP) and 77 matched healthy controls (HC). In the FEP group, NLR values presented a moderate, positive correlation with the pro-inflammatory mediator Prostaglandin E2 levels (r = 0.36, p < 0.001) and a small but significant, positive correlation with cannabis use (r = 0.25, p = 0.017). After controlling for cannabis use, the association between NLR and PGE2 remained significant (beta = 0.31, p = 0.012). In the HC group, NLR values negatively correlated with body mass index (BMI, r = −0.24, p = 0.035) and positively correlated with tobacco use (r = 0.25, p = 0.031). These findings support a relationship between the elevation of NLR values and an elevated expression of proinflammatory pathways related to stress response in patients with a FEP. In addition, our study highlights the importance of considering variables such as cannabis or tobacco consumption, and BMI when interpreting the results of studies aimed to establish a clinical use of NLR. These considerations may help future research to use NLR as a reliable biomarker to determine immune system status in this population.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

  • Amoretti, Silvia
  • Mezquida, Gisela
  • Verdolini, Norma
  • Bioque, Miquel
  • Sánchez-Torres, Ana M.
  • Pina-Camacho, Laura
  • Zorrilla, Iñaki
  • Trabsa, Amira
  • Rodríguez-Jiménez, Roberto
  • Corripio, Iluminada
  • Sarró, Salvador
  • Ibáñez, Ángela
  • Usall, Judith
  • Segarra, Rafael
  • Vieta, Eduard
  • Roberto, Natalia
  • Ramos-Quiroga, Josep Antoni
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Cuesta, Manuel J.
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Esther
  • Bernardo, Miguel
  • Forte, María Florencia
  • Serra, María
  • Alonso-Solís, Anna
  • Grasa, Eva
  • Corres, Edurne García
  • Fernández Sevillano, Jessica
  • Toll, Alba
  • Martínez-Sadurní, Laura
  • Núñez-Doyle, Aggie
  • Sánchez-Pastor, Luis
  • Pomarol-Clotet, Edith
  • Guerrero-Pedraza, Amalia
  • Butjosa, Anna
  • Pardo, Marta
  • López-Ilundain, José M.
  • Ribeiro, María
  • Saiz-Ruiz, Jerónimo
  • León-Quismondo, Leticia
  • Escartí, María José
  • Contreras, Fernando
  • Cámara, Concepción de la
  • Zabala Rabadán, Arantzazu
  • Portilla, M. Paz
Introduction: Negative symptoms (NS) include asociality, avolition, anhedonia, alogia, and blunted affect and are linked to poor prognosis. It has been suggested that they reflect two different factors: diminished expression (EXP) (blunted affect and alogia) and amotivation/pleasure (MAP) (anhedonia, avolition, asociality). The aim of this article was to examine potential sex differences among first-episode schizophrenia (FES) patients and analyze sex-related predictors of two NS symptoms factors (EXP and MAP) and functional outcome. Material and methods: Two hundred and twenty-three FES (71 females and 152 males) were included and evaluated at baseline, six-months and one-year. Repeated measures ANOVA was used to examine the effects of time and sex on NS and a multiple linear regression backward elimination was performed to predict NS factors (MAP-EXP) and functioning. Results: Females showed fewer NS (p = 0.031; Cohen's d = −0.312), especially those related to EXP (p = 0.024; Cohen's d = −0.326) rather than MAP (p = 0.086), than males. In both male and female group, worse premorbid adjustment and higher depressive symptoms made a significant contribution to the presence of higher deficits in EXP at one-year follow-up, while positive and depressive symptoms predicted alterations in MAP. Finally, in females, lower deficits in MAP and better premorbid adjustment predicted better functioning at one-year follow-up (R2 = 0.494; p < 0.001), while only higher deficits in MAP predicted worse functioning in males (R2 = 0.088; p = 0.012). Conclusions: Slightly sex differences have been found in this study. Our results lead us to consider that early interventions of NS, especially those focusing on motivation and pleasure symptoms, could improve functional outcomes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis

  • Costas-Carrera, Ana
  • Verdolini, Norma
  • Garcia-Rizo, Clemente
  • Mezquida, Gisela
  • Janssen, Joost
  • Valli, Isabel
  • Corripio, Iluminada
  • Sanchez-Torres, Ana M.
  • Bioque, Miquel
  • Lobo, Antonio
  • Gonzalez-Pinto, Ana
  • Rapado-Castro, Marta
  • Vieta, Eduard
  • De la Serna, Helena
  • Mane, Anna
  • Roldan, Alexandra
  • Crossley, Nicolas
  • Penades, Rafael
  • Cuesta, Manuel J.
  • Parellada, Mara
  • Bernardo, Miquel
Patients with a first episode of psychosis (FEP) display clinical, cognitive, and structural brain abnormalities at illness onset. Ventricular enlargement has been identified in schizophrenia since the initial development of neuroimaging techniques. Obstetric abnormalities have been associated with an increased risk of developing psychosis but also with cognitive impairment and brain structure abnormalities. Difficulties during delivery are associated with a higher risk of birth asphyxia leading to brain structural abnormalities, such as ventriculomegaly, which has been related to cognitive disturbances. Methods We examined differences in ventricular size between 142 FEP patients and 123 healthy control participants using magnetic resonance imaging. Obstetric complications were evaluated using the Lewis–Murray scale. We examined the impact of obstetric difficulties during delivery on ventricle size as well as the possible relationship between ventricle size and cognitive impairment in both groups. Results FEP patients displayed significantly larger third ventricle size compared with healthy controls. Third ventricle enlargement was associated with diagnosis (higher volume in patients), with difficulties during delivery (higher volume in subjects with difficulties), and was highest in patients with difficulties during delivery. Verbal memory was significantly associated with third ventricle to brain ratio. Conclusions Our results suggest that difficulties during delivery might be significant contributors to the ventricular enlargement historically described in schizophrenia. Thus, obstetric complications may contribute to the development of psychosis through changes in brain architecture.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

  • Clougher, Derek
  • Forte, María Florencia
  • Mezquida, Gisela
  • Sánchez-Torres, Ana M.
  • Serra-Navarro, María
  • Penadés, Rafael
  • Lobo, Antonio
  • González Pinto, Ana
  • Panadero, Rocío
  • Roldán, Alexandra
  • Vieta, Eduard
  • de la Serna, Elena
  • Trabsa, Amira
  • Martínez-Arán, Anabel
  • Torrent, Carla
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ramos-Quiroga, Josep Antoni
  • Cuesta, Manuel J.
  • Bernardo, Miquel
  • Amoretti, Silvia
  • Salmerón, Sergi
  • Arbelo, Néstor
  • Ferrer-Quintero, Marta
  • Echevarría, Ana
  • Selma, Judit
  • Grasa, Eva Ma
  • Marin, Julen
  • Mar, Lorea
  • De la Cámara, Concepción
  • Ruíz-Lázaro, Pedro M
  • Nacher, Juan
  • Nicolas, Carlos Cañete
  • Mané, Anna
  • Toll, Alba
  • Solé, Brisa
  • Mallorqui, Aida
  • Castro-Fornieles, Josefina
  • Baeza, Inmaculada
  • Contreras, Fernando
  • Sáiz, Pilar A.
  • Bobes-Bascarán, Teresa
  • Segarra, Rafael
  • Zabala, Arantzazu
  • Scala, Mauro
  • Rodriguez-Jimenez, Roberto
  • Usall, Judith
  • Butjosa, Anna
  • Pomarol-Clotet, Edith
  • García-León, Maria Ángeles
  • Ibañez, Angela
  • Moreno-Izco, Lucía
  • Balanzá-Martínez, Vicent
Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia

  • Segura, Alex-González
  • Prohens, Llucia
  • Julià, Laura
  • Amoretti, Silvia
  • RIbero, Maria
  • Pino-Camacho, Laura
  • Cano-Escalera, Guillermo
  • Mane, Anna
  • Rodriguez-Jimenez, Roberto
  • Roldan, Alexandra
  • Sarró, Salvador
  • Ibañez, Angela
  • Usall, Judith
  • Lobo, Antonio
  • Garcia-Rizo, Clemente
  • Cuesta, Manuel Jesus
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Esther
  • Bernardo, Miquel
  • Mas, Sergi
  • Rodríguez, Natalia
  • Perez-Ramos, Anaid
  • Salmeron, Sergi
  • González-Peñas, Javier
  • Gurriarán, Xaquín
  • Farré, Adriana
  • Pousa, Esther
  • Zorrilla, Iñaki
  • Mar-Barrutia, Lorea
  • Trabsa, Amira
  • Martinez, Laura
  • Sánchez-Cabezudo, Ángeles
  • Jiménez-López, Estela
  • Pomarol-Clotet, Edith
  • Salvador, Raymond
  • Butjosa, Anna
  • Elena, Rubio-Abadal
  • Moreno-Izco, Lucía
  • Torres, Ana M. Sánchez
  • Saiz, Jeronimo
  • León-Quismondo, Leticia
  • Rivero, Olga
  • González-Blanco, Leticia
  • Cámara Izquierdo, Concepción de la
Both genetic and environmental factors have been found to play a significant role in psychosis relapse, either independently or through their synergistic interaction. Recently, DNA methylation (DNAm) has been proposed through the calculation of methylation profile scores (MPS). The aim of the present study is to evaluate the association of MPS as a surrogate marker of the biological impact of early stressful life events (including stressful intrauterine conditions and obstetric complications, childhood adversity and toxic habits), with the risk of schizophrenia (SCZ) relapse. 91 participants from a cohort of first-episode schizophrenia (FES) patients with less than five years of evolution were classified as non-relapse (patients who had not experienced a relapse after 3 years of enrollment) or relapse (patients who relapsed during the 3-year follow-up). As inclusion criteria, patients fulfilled Andreasen's criteria of symptomatic remission. Genome-wide DNA methylation (DNAm) was profiled and fourteen MPS reflecting environmental exposure were constructed including both early stressful life events (including stressful intrauterine conditions and delivery issues, childhood adversity) and toxic habits. Increased levels of MPS reflecting gestational diabetes (p = 0.009), hypertensive disorders during pregnancy (p = 0.004), pre-eclampsia (p = 0.049), early preterm birth (p = 0.030), childhood adversity abuse (p = 0.021) and all childhood adversity (p = 0.030) were significantly associated with an increased risk of relapse. Our study suggests that changes in specific methylation patterns may represent one of the biological mechanisms linking early stressful life events to an increased risk of relapse.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years

  • Verdolini N.
  • Amoretti S.
  • Mezquida G.
  • Cuesta M.J.
  • Pina-Camacho L.
  • García-Rizo C.
  • Lobo A.
  • González-Pinto A.
  • Merchán-Naranjo J.
  • Corripio I.
  • Salagre E.
  • Baeza I.
  • Bergé D.
  • Garriga M.
  • Bioque M.
  • Vallespir C.
  • Serra M.
  • Vieta E.
  • Bernardo M.
The aim of the present study was to evaluate the contribution of family environment styles and psychiatric family history on functioning of patients presenting first-episode psychosis (FEP). Patients with FEP and healthy controls (HC) were assessed at baseline and after 2 years. The Functional Assessment Short Test (FAST) was used to assess functional outcome and the Family Environment Scale (FES) to evaluate family environment. Linear regressions evaluated the effect that family environment exerts on functioning at baseline and at 2-year follow-up, when FEP patients were diagnosed according to non-affective (NA-PSYCH) or affective psychoses (A-PSYCH). The influence of a positive parents’ psychiatric history on functioning was evaluated through one-way between-groups analysis of covariance (ANCOVA) models, after controlling for family environmental styles. At baseline, FEP patients presented moderate functioning impairment, significantly worse than HC (28.65±16.17 versus 3.25±7.92; p<0.001, g = 1.91). At 2-year follow-up, the functioning of NA-PSYCH patients was significantly worse than in A-PSYCH (19.92±14.83 versus 12.46±14.86; p = 0.020, g = 0.50). No specific family environment style was associated with functioning in FEP patients and HC. On the contrary, a positive psychiatric father''s history influenced functioning of FEP patients. After 2 years, worse functioning in NA-PSYCH patients was associated with lower rates of active-recreational and achievement orientated family environment and with higher rates of moral-religious emphasis and control. In A-PSYCH, worse functioning was associated with higher rates of conflict in the family. Both family environment and psychiatric history influence psychosocial functioning, with important implications for early interventions, that should involve both patients and caregivers.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Impact of relapse in BDNF receptors expression in patients with a first episode of schizophrenia

  • Bioque, Miquel
  • Llorca-Bofí, Vicent
  • MacDowell, Karina S
  • Amoretti, Sílvia
  • Mezquida, Gisela
  • Cuesta, Manuel J.
  • Díaz-Caneja, Covadonga M.
  • Ibáñez, Ángela
  • Segarra, Rafael
  • González-Pinto, Ana
  • Roldán, Alexandra
  • Sáiz, Pilar A.
  • Mané, Anna
  • Lobo, Antonio
  • Martínez-Pinteño, Albert
  • Cano-Escalera, Guillermo
  • Berrocoso, Esther
  • Bernardo, Miquel
  • 2EPs Group
Background and Hypothesis Relapsing after a first episode of schizophrenia (FES) is a main predictor of clinical and functional prognosis. Brain-derived neurotrophic factor (BDNF) plays a critical role in neuronal development and plasticity, and its signaling may be altered by successive relapses. Design We assessed the impact of first relapse in the expression of the 2 isoforms of the BDNF tropomyosin-related kinase B (TrkB) receptor (active full-length TrkB-F and inactive truncated TrkB-T) in peripheral blood mononuclear cells from 53 FES patients in clinical remission followed up for 3 years. Results The group of participants that relapsed (n = 24) during the follow-up presented a significant decrease in the expression of the active TrkB-F receptor compared to baseline (M = 100 ± 28.13 vs. M = 83.42 ± 33.84, t = 2.5, P = .02), with no changes in the inactive TrkB-T receptor expression nor in BDNF plasma levels. This decrease also led to a significant decline in the F/T ratio (M = 1.13 ± 0.38 vs. 0.94 ± 0.36, t = 2.17, P = .041). No significant differences were found in the receptors’ expression nor in plasma levels in the group of cases that remained in remission (n = 29). These results were not associated with baseline differences between the groups in terms of the BDNF signaling pathway biomarkers, clinical or treatment variables. Conclusions These findings highlight the biological impact that a relapse produces over the systemic BDNF-TrkB signaling pathway, potentially undermining crucial neuronal functions. Identifying the actors involved can help design specific interventions for relapse prevention and improve the functional prognosis of people in the early stages of schizophrenia.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Obstetric complications, cortical gyrification, and cognition in first-episode psychosis

  • Costas-Carrera, Ana
  • Verdolini, Norma
  • Mezquida, Gisela
  • Forte, Maria Florencia
  • Janssen, Joost
  • Garcia-Rizo, Clemente
  • Martinez-Aran, Anabel
  • Andres-Camazon, Pablo
  • Sánchez-Torres, Ana Maria
  • Berge, Daniel
  • de la Serna, Elena
  • Penades, Rafael
  • Valli, Isabel
  • Amoretti, Silvia
Background: Obstetric complications (OCs) are associated with cognitive and brain abnormalities observed in patients with schizophrenia. Gyrification, a measure of cortical integrity sensitive to events occurring during the prenatal and perinatal periods, is also altered in first-episode psychosis (FEP). We examined the relationship between OCs and gyrification in FEP, as well as whether gyrification mediates the relationship between OCs and cognition. Methods: We examined differences in the Local Gyrification Index (LGI) for the frontal, parietal, temporal, occipital, and cingulate cortices between 139 FEP patients and 125 healthy controls (HCs). Regression analyses explored whether OCs and diagnosis interact to explain LGI variation. Parametric mediation analyses were conducted to assess the effect of LGI on the relationship between OCs and cognition for FEP and HC. Results: Significant LGI differences were observed between FEP patients and HC in the left parietal and bilateral cingulate and occipital cortices. There was a significant interaction between OCs and diagnosis on the left cingulate cortex (LCC) that was specific to males (p = 0.04) and was driven by gestational rather than intrauterine OCs. In HCs, OCs had a direct effect on working memory (WM) (p = 0.048) in the mediation analysis, whereas in FEP, we observed no significant effect of OCs on either verbal or WM. Conclusions: OCs interact with diagnosis to predict LCC gyrification, such that males with FEP exposed to OCs exhibit the lowest LGI. OCs influence WM, and LCC gyrification may mediate this relation only in HC, suggesting a differential neurodevelopmental process in psychosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exploring Risk and Resilient Profiles for Functional Impairment and Baseline Predictors in a 2-Year Follow-Up First-Episode Psychosis Cohort Using Latent Class Growth Analysis

  • Salagre, Estela|||0000-0001-6352-5179
  • Grande, Iria|||0000-0002-0137-0666
  • Solé, Brisa|||0000-0003-1673-8248
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Díaz-Caneja, Covadonga M.|||0000-0001-8538-3175
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Moreno, Carmen|||0000-0003-0541-4846
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Verdolini, Norma|||0000-0001-9488-2881
  • Carvalho, André F.
  • Vieta, Eduard|||0000-0002-0548-0053
  • Bernardo, Miquel|||0000-0001-8748-6717
Being able to predict functional outcomes after First-Episode Psychosis (FEP) is a major goal in psychiatry. Thus, we aimed to identify trajectories of psychosocial functioning in a FEP cohort followed-up for 2 years in order to find premorbid/baseline predictors for each trajectory. Additionally, we explored diagnosis distribution within the different trajectories. A total of 261 adults with FEP were included. Latent class growth analysis identified four distinct trajectories: Mild impairment-Improving trajectory (Mi-I) (38.31% of the sample), Moderate impairment-Stable trajectory (Mo-S) (18.39%), Severe impairment-Improving trajectory (Se-I) (12.26%), and Severe impairment-Stable trajectory (Se-S) (31.03%). Participants in the Mi-I trajectory were more likely to have higher parental socioeconomic status, less severe baseline depressive and negative symptoms, and better premorbid adjustment than individuals in the Se-S trajectory. Participants in the Se-I trajectory were more likely to have better baseline verbal learning and memory and better premorbid adjustment than those in the Se-S trajectory. Lower baseline positive symptoms predicted a Mo-S trajectory vs. Se-S trajectory. Diagnoses of Bipolar disorder and Other psychoses were more prevalent among individuals falling into Mi-I trajectory. Our findings suggest four distinct trajectories of psychosocial functioning after FEP. We also identified social, clinical, and cognitive factors associated with more resilient trajectories, thus providing insights for early interventions targeting psychosocial functioning.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A longitudinal study of gene expression in first-episode schizophrenia, exploring relapse mechanisms by co-expression analysis in peripheral blood

  • Gassó, Patricia|||0000-0001-6930-3454
  • Rodríguez, Natalia|||0000-0002-9618-9383
  • Martínez Piñeiro, Alberto|||0000-0003-2035-5979
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Ribeiro-Fernández, María
  • González-Peñas, Javier|||0000-0002-3850-3012
  • Zorrilla, Iñaki|||0000-0001-6444-8208
  • Martínez Sadurní, Laura|||0000-0001-8693-8902
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Sarró, Salvador|||0000-0003-1835-2189
  • Ibáñez, Ángela
  • Usall, Judith|||0000-0002-1746-7737
  • Lobo, Antonio|||0000-0002-9098-655X
  • Moren, C.
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Parellada, Mara|||0000-0001-7977-3601
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Berrocoso, E.
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Mas, Sergi|||0000-0003-3336-6298
  • Alonso-Solís, Anna|||0000-0002-5393-9391
  • Grasa, Eva|||0000-0003-1100-7489
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Trabsa, Amira|||0000-0002-8669-0676
Little is known about the pathophysiological mechanisms of relapse in first-episode schizophrenia, which limits the study of potential biomarkers. To explore relapse mechanisms and identify potential biomarkers for relapse prediction, we analyzed gene expression in peripheral blood in a cohort of first-episode schizophrenia patients with less than 5 years of evolution who had been evaluated over a 3-year follow-up period. A total of 91 participants of the 2EPs project formed the sample for baseline gene expression analysis. Of these, 67 provided biological samples at follow-up (36 after 3 years and 31 at relapse). Gene expression was assessed using the Clariom S Human Array. Weighted gene co-expression network analysis was applied to identify modules of co-expressed genes and to analyze their preservation after 3 years of follow-up or at relapse. Among the 25 modules identified, one module was semi-conserved at relapse (DarkTurquoise) and was enriched with risk genes for schizophrenia, showing a dysregulation of the TCF4 gene network in the module. Two modules were semi-conserved both at relapse and after 3 years of follow-up (DarkRed and DarkGrey) and were found to be biologically associated with protein modification and protein location processes. Higher expression of DarkRed genes was associated with higher risk of suffering a relapse and early appearance of relapse (p = 0.045). Our findings suggest that a dysregulation of the TCF4 network could be an important step in the biological process that leads to relapse and suggest that genes related to the ubiquitin proteosome system could be potential biomarkers of relapse.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis

  • Solanes, Aleix|||0000-0002-2491-200X
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Janssen, Joost|||0000-0001-7613-2067
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Arango, Celso|||0000-0003-3382-4754
  • Vieta, Eduard|||0000-0002-0548-0053
  • Castro-Fornieles, Josefina|||0000-0003-0632-2687
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Albacete, Auria|||0000-0003-4156-4972
  • Giné Serven, Eloi|||0000-0002-3130-5566
  • Parellada, Mara|||0000-0001-7977-3601
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Radua, Joaquim|||0000-0003-1240-5438
Detecting patients at high relapse risk after the first episode of psychosis (HRR-FEP) could help the clinician adjust the preventive treatment. To develop a tool to detect patients at HRR using their baseline clinical and structural MRI, we followed 227 patients with FEP for 18-24 months and applied MRIPredict. We previously optimized the MRI-based machine-learning parameters (combining unmodulated and modulated gray and white matter and using voxel-based ensemble) in two independent datasets. Patients estimated to be at HRR-FEP showed a substantially increased risk of relapse (hazard ratio = 4.58, P < 0.05). Accuracy was poorer when we only used clinical or MRI data. We thus show the potential of combining clinical and MRI data to detect which individuals are more likely to relapse, who may benefit from increased frequency of visits, and which are unlikely, who may be currently receiving unnecessary prophylactic treatments. We also provide an updated version of the MRIPredict software.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years

  • Verdolini, Norma|||0000-0001-9488-2881
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Merchán-Naranjo, Jessica
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Salagre, Estela|||0000-0001-6352-5179
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Garriga, Marina|||0000-0001-7312-4969
  • Bioque, Miquel|||0000-0001-6887-7149
  • Vallespir, Catalina
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Vieta, Eduard|||0000-0002-0548-0053
  • Bernardo, Miquel|||0000-0001-8748-6717
The aim of the present study was to evaluate the contribution of family environment styles and psychiatric family history on functioning of patients presenting first-episode psychosis (FEP). Patients with FEP and healthy controls (HC) were assessed at baseline and after 2 years. The Functional Assessment Short Test (FAST) was used to assess functional outcome and the Family Environment Scale (FES) to evaluate family environment. Linear regressions evaluated the effect that family environment exerts on functioning at baseline and at 2-year follow-up, when FEP patients were diagnosed according to non-affective (NA-PSYCH) or affective psychoses (A-PSYCH). The influence of a positive parents' psychiatric history on functioning was evaluated through one-way between-groups analysis of covariance (ANCOVA) models, after controlling for family environmental styles. At baseline, FEP patients presented moderate functioning impairment, significantly worse than HC (28.65±16.17 versus 3.25±7.92; p<0.001, g = 1.91). At 2-year follow-up, the functioning of NA-PSYCH patients was significantly worse than in A-PSYCH (19.92±14.83 versus 12.46±14.86; p = 0.020, g = 0.50). No specific family environment style was associated with functioning in FEP patients and HC. On the contrary, a positive psychiatric father's history influenced functioning of FEP patients. After 2 years, worse functioning in NA-PSYCH patients was associated with lower rates of active-recreational and achievement orientated family environment and with higher rates of moral-religious emphasis and control. In A-PSYCH, worse functioning was associated with higher rates of conflict in the family. Both family environment and psychiatric history influence psychosocial functioning, with important implications for early interventions, that should involve both patients and caregivers.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique

  • Amoretti, Silvia|||0000-0001-6017-2734
  • Verdolini, Norma|||0000-0001-9488-2881
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Rabelo-da-Ponte, Francisco Diego|||0000-0001-9016-2414
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Gomez-Ramiro, Marta|||0000-0002-3463-0866
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Díaz-Caneja, Covadonga M.|||0000-0001-8538-3175
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Vieta, Eduard|||0000-0002-0548-0053
  • de la Serna, Elena|||0000-0002-7869-9881
  • Mané, Anna|||0000-0003-2127-349X
  • Solé, Brisa|||0000-0003-1673-8248
  • Carvalho, André F.
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Bernardo, Miquel|||0000-0001-8748-6717
The extreme variability in symptom presentation reveals that individuals diagnosed with a first-episode psychosis (FEP) may encompass different sub-populations with potentially different illness courses and, hence, different treatment needs. Previous studies have shown that sociodemographic and family environment factors are associated with more unfavorable symptom trajectories. The aim of this study was to examine the dimensional structure of symptoms and to identify individuals' trajectories at early stage of illness and potential risk factors associated with poor outcomes at follow-up in non-affective FEP. One hundred and forty-four non-affective FEP patients were assessed at baseline and at 2-year follow-up. A Principal component analysis has been conducted to identify dimensions, then an unsupervised machine learning technique (fuzzy clustering) was performed to identify clinical subgroups of patients. Six symptom factors were extracted (positive, negative, depressive, anxiety, disorganization and somatic/cognitive). Three distinct clinical clusters were determined at baseline: mild; negative and moderate; and positive and severe symptoms, and five at follow-up: minimal; mild; moderate; negative and depressive; and severe symptoms. Receiving a low-dose antipsychotic, having a more severe depressive symptomatology and a positive family history for psychiatric disorders were risk factors for poor recovery, whilst having a high cognitive reserve and better premorbid adjustment may confer a better prognosis. The current study provided a better understanding of the heterogeneous profile of FEP. Early identification of patients who could likely present poor outcomes may be an initial step for the development of targeted interventions to improve illness trajectories and preserve psychosocial functioning.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The effect of early life events on glucose levels in first-episode psychosis

  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Cabrera, Bibiana|||0000-0002-7749-5449
  • Bioque, Miquel|||0000-0001-6887-7149
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Díaz-Caneja, Covadonga M.|||0000-0001-8538-3175
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Vieta, Eduard|||0000-0002-0548-0053
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • García-Portilla, María Paz|||0000-0003-3643-1622
  • Gutiérrez Fraile, Miguel
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Garriga, Marina|||0000-0001-7312-4969
  • Fernández Egea, Emilio|||0000-0003-4128-8955
  • Bernardo, Miquel|||0000-0001-8748-6717
First episode of psychosis (FEP) patients display a wide variety of metabolic disturbances at onset, which might underlie these patients' increased morbidity and early mortality. Glycemic abnormalities have been previously related to pharmacological agents; however, recent research highlights the impact of early life events. Birth weight (BW), an indirect marker of the fetal environment, has been related to glucose abnormalities in the general population over time. We aim to evaluate if BW correlates with glucose values in a sample of FEP patients treated with different antipsychotics. Two hundred and thirty-six patients were included and evaluated for clinical and metabolic variables at baseline and at 2, 6, 12, and 24 months of follow-up. Pearson correlations and linear mixed model analysis were conducted to analyze the data. Antipsychotic treatment was grouped due to its metabolic risk profile. In our sample of FEP patients, BW was negatively correlated with glucose values at 24 months of follow-up [r=-0.167, p=0.037]. BW showed a trend towards significance in the association with glucose values over the 24-month period (F=3.22; p=0.073) despite other confounders such as age, time, sex, body mass index, antipsychotic type, and chlorpromazine dosage. This finding suggests that BW is involved in the evolution of glucose values over time in a cohort of patients with an FEP, independently of the type of pharmacological agent used in treatment. Our results highlight the importance of early life events in the later metabolic outcome of patients.